Daniel D. Han, MS

G2 MD/PhD student @RocMSTP 🐝 | @URSMDCIG Leader🫀| @UCBerkeley '20 🐻

[Daniel D. Han, MS @DanielDWHan]

Excited to announce that my first publication at Small Lab is out!!!! Thank you @Eric66867284 always for your support! Looking forward to continue the research to unlock mechanisms of arrhythmogenic cardiomyopathy!! @URochester_SMD @URMed_DeptMed @Pathology_URMC @UR_Med @RocMSTP

[Circ: Heart Failure @CircHF]

Epicardium-derived fibroblasts drive the fibro-inflammatory response in Pkp2-deficient arrhythmogenic cardiomyopathy #URochesterResearch @MarioDelmar3 @DanielDWHan @Eric66867284 https://t.co/I4DvitbsaC

[Daniel D. Han, MS @DanielDWHan]

Excited to have our work highlighted! @VKutyifa

[European Society of Cardiology Journals @ESC_Journals]

Effects of metabolic syndrome on cardiovascular outcomes in non-obese heart failure patients. @ESC Heart Failure https://t.co/T86wU91Qom

@EJHFEiC @JanBiegus @Ppponikowski #HFA_ESC @hvanspall @ShelleyZieroth @FudimMarat @gcfmd @MarcoMetra @GianluSava #ESCHeartFailure

[URochester Medicine Department of Medicine @URMed_DeptMed]

New #URochesterResearch uncovers a new biomarker of heart cells that surround the dead tissue left by a heart attack.

@Eric66867284 & his team developed a new mouse model to study these cells & their role in heart repair & regeneration.

More in @CircAHA: https://t.co/MNUF5VJXb6

[Valentina Kutyifa @VKutyifa]

Late-breaker presentation is Tuesday 11:00 am on novel GDMT in #BIOLIBRA don’t miss it #EHRA2026 @ESCardioNews

[Circulation @CircAHA]

Sprr1a acts a novel marker for specific subpopulation of border zone cardiomyocytes in mice, that survive myocardial infarction, facilitating their direct visualization, isolation, and longitudinal tracking. https://t.co/qFJYpHQZZr

[Daniel D. Han, MS @DanielDWHan]

You can read more here: https://t.co/HDpJQpX7aP

[Daniel D. Han, MS @DanielDWHan]

Excited to share that my first, first-author case report is published in the International Journal of Cardiothoracic Imaging. We looked at a case of Desmoplakin cardiomyopathy with clear ring-like lesion in Late-Gadolinium Enhancement. Thank you @JoslinKapr34515 for your support!

[Daniel D. Han, MS @DanielDWHan]

You can read more here: https://t.co/VGOZPdTi2J

[Daniel D. Han, MS @DanielDWHan]

My first, first-author clinical paper is out @ESCHeartFailure Non-Obese patients with Metabolic Syndrome has similar high HF risks as obese. Having Diabetes further raised the risk! Our work calls for more focus for managing these patients! Thank you @VKutyifa for your mentorship

[Daniel D. Han, MS @DanielDWHan]

Honored to organize the symposium with @SominskyLevy Please register and submit your abstracts if you have any interesting data!! Also, please come out to hear our keynote presentation from Dr. Rajan Jain #Cardiology #nucleus

[Rochester MSTP @RocMSTP]

Excited to share that the 14th Annual Medical Scientist Research Symposium is on Friday, April 3rd, 2026!

This year’s keynote speaker is Rajan Jain, MD, William Wikoff Smith Associate Professor of Medicine and Cell & Developmental Biology at the University of Pennsylvania!

[The Lancet @TheLancet]

VEXAS syndrome is a newly discovered multisystemic disease affecting most organs.

A Review provides a comprehensive overview of VEXAS syndrome, including the disease's discovery, diagnosis, and treatment: https://t.co/2BPPLfwDD9

[Daniel D. Han, MS @DanielDWHan]

It was a wonderful opportunity to discuss about potential sex differences in heart failure outcomes in patients with metabolic syndrome and implantable cardiac devices #MADIT @RocMSTP @UR_Med @URochester_SMD

[Valentina Kutyifa @VKutyifa]

Our brilliant MSTP student, Daniel Han presenting on sex-differences in metabolic syndrome at the Research in Health Equity Symposium @URMC_DeptMed @DanielDWHan

[Valentina Kutyifa @VKutyifa]

Our brilliant MSTP student, Daniel Han presenting on sex-differences in metabolic syndrome at the Research in Health Equity Symposium @URMC_DeptMed @DanielDWHan

[Daniel D. Han, MS @DanielDWHan]

@VKutyifa @URMC_DeptMed Thank you so much for your mentorship!!

[Henry Han @HanCardiomd]

Several impactful papers influencing the treatment of patients with #HeartFailure have been published in 2025

@ESC_Journals #EHJ

https://t.co/MDBZMMR9Od

[Nancy Pelosi @SpeakerPelosi]

On #KoreanAmericanDay, we honor the leadership, service and culture Korean Americans have contributed and continue to contribute to San Francisco and our country.

The Korean American community is an enduring part of our nation’s story—and America is all the stronger for it.

[Valentina Kutyifa @VKutyifa]

Trial almost complete!! Our NIH-funded HIS-CRT trial enrolled 115 of 120 participants, enrolling females now. We need evidence on the efficacy of HIS-CRT to accurately treat female patients. Our fantastic patient representative, Rhonda Monroe shared insights on "HIS-CRT for HER". @DrRoderickTung @kennethellenbogen @NIH #EPPEEPS #ClinicalTrials

https://t.co/rppDAYo3cD

[Daniel D. Han, MS @DanielDWHan]

Great Interview Leila!!!

[Leila Mohammadi, MD, PhD @LeilaMohMDPhD]

Appreciate the opportunity to speak with KCRA 3 Sacramento about cannabis use in seniors, and shared insights from our CANDIDE study about the cardiovascular effects of cannabis. @UCSFCardiology @JAMACardio
https://t.co/ysWapzhBEx

[Circulation @CircAHA]

In the SARAH trial, sacubitril-valsartan reduced LV dysfunction in patients with anthracylcine related cardiotoxicity @Bocchi @MBittencourtMD @monicaAGrinberg @lukadalech @larimosko https://t.co/Y0kVwwbT1V